Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;52(12):1410-1412.
doi: 10.1016/j.dld.2020.10.001. Epub 2020 Oct 6.

Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection

Timotius Ivan Hariyanto  1 , Ignatius Bima Prasetya  2 , Andree Kurniawan  3
Affiliations
Review

Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection

Timotius Ivan Hariyanto et al. Dig Liver Dis. 2020 Dec.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Forest plot that demonstrates the association of PPI use with severe COVID-19 disease (A) and mortality from COVID-19 (B). Events mean severe outcomes or mortality of the disease.
See this image and copyright information in PMC

References

    1. Hariyanto T.I., Kurniawan A. Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection. Obes Med. 2020;19 doi: 10.1016/j.obmed.2020.100290. - DOI - PMC - PubMed
    1. Pranata R., Permana H., Huang I., Lim M.A., Soetedjo N.N.M., Supriyadi R., et al. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Diabetes Metab Syndr. 2020;14(5):983–990. doi: 10.1016/j.dsx.2020.06.047. - DOI - PMC - PubMed
    1. Hariyanto T.I., Kurniawan A. Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr. 2020;14(6):1613–1615. doi: 10.1016/j.dsx.2020.08.023. - DOI - PMC - PubMed
    1. Moayyedi P., Delaney B.C., Vakil N., Forman D., Talley N.J. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology. 2004;127(5):1329–1337. doi: 10.1053/j.gastro.2004.08.026. - DOI - PubMed
    1. Wang C.H., Li C.H., Hsieh R., Fan C.Y., Hsu T.C., Chang W.C., et al. Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta-analysis of randomized controlled trials and observational studies. Expert Opin Drug Saf. 2019;18(3):163–172. - PubMed

Substances